MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202647070975 A) filed by Pentixapharm AG on June 08, 2026, for Antibodies Against Cd24.
Inventors include Gellert, Johanna; Danielczyk, Antje; Kehler, Patrik; Bahrke, Sven; Jkel, Anika; Weis, Manon Number; Lischke, Timo; Gurka, Stephanie; Marinoff, Sophie; Stckl, Lars; and Hartung, Evelyn.
The application for the patent was published on June 19, 2026, under issue no. 25/2026.
Abstract: The present invention pertains to anti-CD24 antibodies which bind CD24 in an O-glycosylation-dependent manner. Thereby, the antibodies are specific for tumor- associated CD24. The invention further provides pharmaceutical compositions containing said anti-CD24 antibodies and their use in cancer treatment.
Disclaimer: Curated by HT Syndication.
